Literature DB >> 17619868

Serum and cerebrospinal fluid morphine pharmacokinetics after single doses of intravenous and intramuscular morphine after hip replacement surgery.

O Dale1, J Thoner, T Nilsen, T Tveita, P C Borchgrevink, P Klepstad.   

Abstract

AIM: To compare the time course of morphine and metabolite concentrations in serum and cerebrospinal fluid (CSF) after intravenous and intramuscular administration after surgery.
METHODS: This was a randomized double-blind, double-dummy study in patients who had undergone hip replacement surgery. Morphine (M, 10 mg) was administered intravenously (IV) or intramuscularly (IM). Arterial blood and CSF samples (from a spinal catheter) were drawn simultaneously at 10, 30, 60, and 120 min after administration. Morphine and metabolites [morphine-3-glucuronide (M-3-G), morphine-6-glucuronide (M-6-G), and normorphine (NM)] were determined by a validated liquid chromatography-tandem mass spectrometry method.
RESULTS: Thirty-eight patients were included: 13 men and 25 women, 20 in the IV, 18 in the IM group. Serum concentrations of M after 10 min were consistently higher after IM than IV, concentrations of M-3-G and M-6-G after IM surpassed those of IV after 45 min. NM was not found. None of the metabolites was found in CSF. CSF morphine concentrations and CSF/serum concentration ratios were consistently higher after IV compared to IM. The mean AUC(CSF)/AUC(serum) (0-120 min) concentration ratios were 0.18 and 0.09 after IV and IM, respectively.
CONCLUSIONS: The uptake of morphine to the CSF was consistently higher after IV administration than after IM already after 10 min. The higher CSF concentration may be caused by an initially higher morphine blood/CSF gradient following IV morphine injection. The pharmacokinetic findings are compatible with a more rapid and extensive initial effect of IV morphine compared with IM.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17619868     DOI: 10.1007/s00228-007-0329-x

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  21 in total

1.  The acute pain service.

Authors:  L B Ready
Journal:  Acta Anaesthesiol Belg       Date:  1992

2.  Determination of morphine, morphine-3-glucuronide and morphine-6-glucuronide in human serum by solid-phase extraction and liquid chromatography-mass spectrometry with electrospray ionisation.

Authors:  N Tyrefors; B Hyllbrant; L Ekman; M Johansson; B Långström
Journal:  J Chromatogr A       Date:  1996-04-05       Impact factor: 4.759

3.  Pharmacokinetic modeling of M6G formation after oral administration of morphine in healthy volunteers.

Authors:  J Lötsch; M Weiss; G Ahne; G Kobal; G Geisslinger
Journal:  Anesthesiology       Date:  1999-04       Impact factor: 7.892

4.  Pharmacokinetic quantification of the exchange of drugs between blood and cerebrospinal fluid in man.

Authors:  R Nau; G Zysk; A Thiel; H W Prange
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

5.  Plasma morphine concentrations after intramuscular injection into the deltoid or gluteal muscles.

Authors:  T Kirkpatrick; P D Henderson; W S Nimmo
Journal:  Anaesthesia       Date:  1988-04       Impact factor: 6.955

6.  Analysis of morphine and its major metabolites by differential radioimmunoassay.

Authors:  C W Hand; R A Moore; H J McQuay; M C Allen; J W Sear
Journal:  Ann Clin Biochem       Date:  1987-03       Impact factor: 2.057

7.  Pharmacokinetic modelling of morphine, morphine-3-glucuronide and morphine-6-glucuronide in plasma and cerebrospinal fluid of neurosurgical patients after short-term infusion of morphine.

Authors:  Ingolf Meineke; Stefan Freudenthaler; Ute Hofmann; Elke Schaeffeler; Gerd Mikus; Matthias Schwab; Hilmar W Prange; Christoph H Gleiter; J Brockmöller
Journal:  Br J Clin Pharmacol       Date:  2002-12       Impact factor: 4.335

8.  Randomized, double-blind, placebo-controlled study of the effect of rectal paracetamol on morphine consumption after abdominal hysterectomy.

Authors:  O Kvalsvik; P C Borchgrevink; L Hagen; O Dale
Journal:  Acta Anaesthesiol Scand       Date:  2003-04       Impact factor: 2.105

9.  CSF and plasma pharmacokinetics of intramuscular morphine.

Authors:  G Nordberg; L Borg; T Hedner; T Mellstrand
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

10.  Cerebral uptake of morphine in the pig calculated from arterio-venous plasma concentration gradients: an alternative to tissue microdialysis.

Authors:  S Björkman; J Akeson; M Helfer; A Fyge; L L Gustafsson
Journal:  Life Sci       Date:  1995       Impact factor: 5.037

View more
  3 in total

1.  Evidence that intrathecal morphine-3-glucuronide may cause pain enhancement via toll-like receptor 4/MD-2 and interleukin-1beta.

Authors:  S S Lewis; M R Hutchinson; N Rezvani; L C Loram; Y Zhang; S F Maier; K C Rice; L R Watkins
Journal:  Neuroscience       Date:  2010-01-20       Impact factor: 3.590

Review 2.  Pharmacokinetics and dosage adjustment in patients with renal dysfunction.

Authors:  Roger K Verbeeck; Flora T Musuamba
Journal:  Eur J Clin Pharmacol       Date:  2009-06-20       Impact factor: 2.953

Review 3.  The optimal choice of medication administration route regarding intravenous, intramuscular, and subcutaneous injection.

Authors:  Jing-Fen Jin; Ling-Ling Zhu; Meng Chen; Hui-Min Xu; Hua-Fen Wang; Xiu-Qin Feng; Xiu-Ping Zhu; Quan Zhou
Journal:  Patient Prefer Adherence       Date:  2015-07-02       Impact factor: 2.711

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.